David Ledbetter is chief clinical officer of Dascena, a personalized medicine company.
David Ledbetter
Chief clinical officer
Dascena
From this contributor
There are no autism-specific genes, just brain genes
There is not yet a single example of a gene that, when mutated, increases the likelihood of autism but not of other neurodevelopmental conditions, including intellectual disability.
There are no autism-specific genes, just brain genes
Developmental disorders should be viewed as continuum
Intellectual disability, autism, epilepsy and schizophrenia should be considered part of a spectrum of developmental brain dysfunction, says David Ledbetter.
Developmental disorders should be viewed as continuum
Explore more from The Transmitter
Neuroscience needs single-synapse studies
Studying individual synapses has the potential to help neuroscientists develop new theories, better understand brain disorders and reevaluate 70 years of work on synaptic transmission plasticity.
Neuroscience needs single-synapse studies
Studying individual synapses has the potential to help neuroscientists develop new theories, better understand brain disorders and reevaluate 70 years of work on synaptic transmission plasticity.
New insights on sex bias in autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 16 February.
New insights on sex bias in autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 16 February.
Neuroscience has a species problem
If our field is serious about building general principles of brain function, cross-species dialogue must become a core organizing principle rather than an afterthought.
Neuroscience has a species problem
If our field is serious about building general principles of brain function, cross-species dialogue must become a core organizing principle rather than an afterthought.